Literature DB >> 7945553

Low density lipoproteins bind more to type I and III collagens by negative charge-dependent mechanisms than to type IV and V collagens.

S Jimi1, N Sakata, A Matunaga, S Takebayashi.   

Abstract

The accumulation of low density lipoprotein (LDL) in the arterial intima is an important characteristic of atherosclerosis. We investigated the mechanisms by which LDL binds to different types of collagen. The binding activities of 125I-labeled human native LDL (nLDL) and copper-oxidized LDL (oxLDL) with different collagen gels prepared in type I collagen-based mixtures with types I, III, IV and V (I+I, I+III, I+IV and I+V, respectively) were examined. A concentration of 20 micrograms LDL protein/150 micrograms collagen/well was used. The diffusion of both nLDL and oxLDL into the collagen gels reached an equilibrium after 48 h. All of the collagen gels showed the same rates of diffusion with both LDLs. The binding activities of oxLDL were significantly greater than those of nLDL (P < 0.001%), while the binding activities for both LDLs followed the order I+I and I+III > I+V > I+IV. However, the increased binding rate of oxLDL compared to nLDL was 1.66 for I+IV, 1.50 for I+V, 1.33 for I+I and 1.19 for I+III. When a 10-fold higher dose of NaCl (1 M) was added to the oxLDL medium, the binding rate of oxLDL was reduced (rate of reduction: 52% (I+I), 48% (I+III), 35% (I+IV), 13% (I+V)). These results suggest that oxLDL binds more to type I and III collagens by negative charge-dependent mechanisms than to type IV and V collagens. Therefore, types I and III collagens may play an important role in trapping LDL, especially oxLDL. Therefore, oxidatively modified LDL may contribute to atherogenesis due to its longer retention in the arterial wall.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7945553     DOI: 10.1016/0021-9150(94)90146-5

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  8 in total

1.  Contribution of macromolecular structure to the retention of low-density lipoprotein at arterial branch points.

Authors:  Gina P Kwon; Jamie L Schroeder; Marcelo J Amar; Alan T Remaley; Robert S Balaban
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

2.  Cholesterol-dependent changes of glycosaminoglycan pattern in human aorta.

Authors:  R Kruse; M Merten; K Yoshida; A Schmidt; W Völker; E Buddecke
Journal:  Basic Res Cardiol       Date:  1996 Sep-Oct       Impact factor: 17.165

3.  ApoE knockout mice expressing human matrix metalloproteinase-1 in macrophages have less advanced atherosclerosis.

Authors:  V Lemaître; T K O'Byrne; A C Borczuk; Y Okada; A R Tall; J D'Armiento
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

4.  Oxidation of high-density lipoprotein HDL3 leads to exposure of apo-AI and apo-AII epitopes and to formation of aldehyde protein adducts, and influences binding of oxidized low-density lipoprotein to type I and type III collagen in vitro1.

Authors:  J Greilberger; G Jürgens
Journal:  Biochem J       Date:  1998-04-01       Impact factor: 3.857

5.  Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta.

Authors:  L B Nielsen; S Stender; M Jauhiainen; B G Nordestgaard
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

6.  Magnetization transfer characteristics in atherosclerotic plaque components assessed by adapted binomial preparation pulses.

Authors:  M Pachot-Clouard; F Vaufrey; L Darrasse; J F Toussainti
Journal:  MAGMA       Date:  1998-11       Impact factor: 2.310

7.  The interaction of plasma sialylated and desialylated lipoproteins with collagen from the intima and media of uninvolved and atherosclerotic human aorta.

Authors:  Igor A Sobenin; Igor V Suprun; Vasiliy P Karagodin; Alexander S Feoktistov; Alexandra A Melnichenko; Alexander N Orekhov
Journal:  J Lipids       Date:  2011-11-17

8.  Nonlinear dynamics of early atherosclerotic plaque formation may determine the efficacy of high density lipoproteins (HDL) in plaque regression.

Authors:  Alexander D Chalmers; Christina A Bursill; Mary R Myerscough
Journal:  PLoS One       Date:  2017-11-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.